These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38102958)

  • 1. Successful treatment of erythrodermic pityriasis rubra pilaris with upadacitinib.
    Li Y; Chen Z; He M; Tan X; Nie S; Zeng Y; Wu Z
    J Eur Acad Dermatol Venereol; 2024 Jul; 38(7):e593-e595. PubMed ID: 38102958
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of erythrodermic pityriasis rubra pilaris with acitretin.
    Atzori L; Zanniello R; Lappi A; Pinna AL; Ferreli C; Rongioletti F; Pilloni L
    Dermatol Ther; 2018 Sep; 31(5):e12694. PubMed ID: 30230135
    [No Abstract]   [Full Text] [Related]  

  • 3. Erythrodermic pityriasis rubra pilaris managed at home: intensive community care followed by ustekinumab.
    Ismail N; Callander J; Williams M; Anstey AV
    Clin Exp Dermatol; 2018 Aug; 43(6):749-751. PubMed ID: 29779249
    [No Abstract]   [Full Text] [Related]  

  • 4. Pityriasis rubra pilaris: evolution of challenges in promising treatment options.
    Sehgal VN; Srivastava G; Verma P
    Skinmed; 2012; 10(1):18-23. PubMed ID: 22324172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eruptive seborrheic keratoses associated with erythrodermic pityriasis rubra pilaris. Possible role of retinoid therapy.
    Schwengle LE; Rampen FH
    Acta Derm Venereol; 1988; 68(5):443-5. PubMed ID: 2461032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythroderma secondary to pityriasis rubra pilaris.
    Gomez-Moyano E; Crespo-Erchiga A
    Indian J Med Res; 2019 Aug; 150(2):206-207. PubMed ID: 31670278
    [No Abstract]   [Full Text] [Related]  

  • 7. Case of pityriasis rubra pilaris progressed to generalized erythroderma following blockade of interleukin-17A, but improved after blockade of interleukin-12/23 p40.
    Matsuda T; Yamazaki F; Ueda-Hayakawa I; Kambe N; Okamoto H
    J Dermatol; 2019 Jan; 46(1):70-72. PubMed ID: 30506728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Erythrodermic pityriasis rubra pilaris].
    Torres Peris V; Aloy Pantín M; Capella Pérez C; Castells Rodellas A
    Med Cutan Ibero Lat Am; 1981; 9(6):423-8. PubMed ID: 7040856
    [No Abstract]   [Full Text] [Related]  

  • 9. The treatment of pityriasis rosea with spirochaeticides.
    HOLLSTROM E
    Acta Derm Venereol; 1948; 28(4):325-9. PubMed ID: 18891990
    [No Abstract]   [Full Text] [Related]  

  • 10. Pityriasis rubra pilaris: a review of diagnosis and treatment.
    Cohen PR; Prystowsky JH
    J Am Acad Dermatol; 1989 May; 20(5 Pt 1):801-7. PubMed ID: 2654219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrodermic pityriasis rubra pilaris: Dramatic response to infliximab therapy.
    Karadag AS; Kavala M; Ozlu E; Ozkanlı S; Zindancı İ; Turkoglu Z
    Indian J Dermatol Venereol Leprol; 2016; 82(1):112. PubMed ID: 26728835
    [No Abstract]   [Full Text] [Related]  

  • 12. Pityriasis Rubra Pilaris With Extensive Follicular Acantholysis Resembling Pemphigus Vulgaris: A Case Report.
    Lilo MT; Yan S; Chapman MS; Linos K
    Am J Dermatopathol; 2019 Jan; 41(1):37-39. PubMed ID: 30045068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pityriasis rubra pilaris in erythrodermic form. Discussion of a tumor of the cheek].
    Duperrat B; Puissant A; Pringuet R; Lauret P
    Bull Soc Fr Dermatol Syphiligr; 1968; 75(3):293-4. PubMed ID: 4235571
    [No Abstract]   [Full Text] [Related]  

  • 14. Transient eruptive seborrhoeic keratoses associated with erythrodermic pityriasis rubra pilaris.
    Sahin MT; Oztürkcan S; Ermertcan AT; Saçar T; Türkdogan P
    Clin Exp Dermatol; 2004 Sep; 29(5):554-5. PubMed ID: 15347352
    [No Abstract]   [Full Text] [Related]  

  • 15. Pityriasis rubra pilaris.
    White KL
    Dermatol Online J; 2003 Oct; 9(4):6. PubMed ID: 14594579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical improvement of pityriasis rubra pilaris with efalizumab in a pediatric patient.
    Gómez M; Ruelas ME; Welsh O; Arcaute HD; Ocampo-Candiani J
    J Drugs Dermatol; 2007 Mar; 6(3):337-9. PubMed ID: 17373198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contribution on the acute onset erythrodermal form of pityriasis rubra pilaris Devergie].
    Rainer R; Zelger J
    Hautarzt; 1966 Apr; 17(4):181-3. PubMed ID: 4228856
    [No Abstract]   [Full Text] [Related]  

  • 18. Erythrodermic Pityriasis Rubra Pilaris Following COVID-19 Vaccination.
    Abdelkader HA; Khedr H; El-Komy MH
    Cutis; 2024 Apr; 113(4):E22-E24. PubMed ID: 38820101
    [No Abstract]   [Full Text] [Related]  

  • 19. Pityriasis rubra pilaris, type 1.
    Booth AV; Ma L
    Dermatol Online J; 2005 Dec; 11(4):9. PubMed ID: 16403381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Erythroderma after corticosteroid withdrawal in papulosquamous dermatosis in children. Diagnosis: pityriasis rubra pilaris, classic juvenile type].
    Terheyden P; Hofmann UB; Hamm H; Bröcker EB
    Hautarzt; 2001 Nov; 52(11):1058-61. PubMed ID: 11757463
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.